Skip to content
Screener

Biohaven BHVN Total Current Assets

Total Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
$64.67B+29.7%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$945.87M+89.1%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$446.86M+65.4%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$573.74M-22.0%
Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
$631.41M+111%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$407.93M+254%

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.17B+41.2%
Enterprise value$2.18B+31.3%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The source filing: Biohaven’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001935979-26-000045
Line itemMarch 31, 2026December 31, 2025
Marketable securities74,74389,180
Prepaid expenses34,66747,022
Other current assets3,1652,170
Total current assets385,649368,329
Property and equipment, net15,25615,964
Intangible assets18,40018,400
Goodwill1,3901,390
Other non-current assets45,71147,364

Item 1. Unaudited Condensed Consolidated Financial Statements

FAQ

What is Biohaven's total current assets?
Biohaven (BHVN) reported total current assets of $385.65M in Q1 2026.
How has Biohaven's total current assets changed year-over-year?
Biohaven's total current assets increased by 0.8% year-over-year, from $382.76M to $385.65M.
What is the long-term trend for Biohaven's total current assets?
Over 4 years (2021 to 2025), Biohaven's total current assets has grown at a 40.4% compound annual growth rate (CAGR), from $94.82M to $368.33M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Ask your AI about Biohaven's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude